I sent an e-mail to Remy Bernada. She told me to send this info to the scientific team of ATH and Prof. Masters as I asked. But sure, ATH has no money or people to deal with amyloidosis, but Masters may have. He now has the PBT2 patent and he is looking for a pharma company to do cooperate to demonstrate the efficacy of PBT2. He is convinced that PBT2 can eliminate amyloid in an early phase of amyloidosis. Animal experiments demonstrated this to happen already in old Prana times with PBT2.
I sent an e-mail to Remy Bernada. She told me to send this info...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $10.07K | 3.191M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 22568002 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 127369917 | 27 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |